1. Home
  2. LGCB vs BCDA Comparison

LGCB vs BCDA Comparison

Compare LGCB & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGCB
  • BCDA
  • Stock Information
  • Founded
  • LGCB 2011
  • BCDA N/A
  • Country
  • LGCB Japan
  • BCDA United States
  • Employees
  • LGCB N/A
  • BCDA N/A
  • Industry
  • LGCB
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGCB
  • BCDA Health Care
  • Exchange
  • LGCB Nasdaq
  • BCDA Nasdaq
  • Market Cap
  • LGCB 8.4M
  • BCDA 9.4M
  • IPO Year
  • LGCB 2023
  • BCDA N/A
  • Fundamental
  • Price
  • LGCB $0.23
  • BCDA $2.54
  • Analyst Decision
  • LGCB
  • BCDA Strong Buy
  • Analyst Count
  • LGCB 0
  • BCDA 1
  • Target Price
  • LGCB N/A
  • BCDA $25.00
  • AVG Volume (30 Days)
  • LGCB 396.0K
  • BCDA 52.7K
  • Earning Date
  • LGCB 03-18-2025
  • BCDA 03-26-2025
  • Dividend Yield
  • LGCB N/A
  • BCDA N/A
  • EPS Growth
  • LGCB N/A
  • BCDA N/A
  • EPS
  • LGCB N/A
  • BCDA N/A
  • Revenue
  • LGCB $10,289,681.00
  • BCDA $71,000.00
  • Revenue This Year
  • LGCB N/A
  • BCDA N/A
  • Revenue Next Year
  • LGCB N/A
  • BCDA N/A
  • P/E Ratio
  • LGCB N/A
  • BCDA N/A
  • Revenue Growth
  • LGCB N/A
  • BCDA N/A
  • 52 Week Low
  • LGCB $0.17
  • BCDA $1.63
  • 52 Week High
  • LGCB $5.71
  • BCDA $6.45
  • Technical
  • Relative Strength Index (RSI)
  • LGCB 41.77
  • BCDA 55.29
  • Support Level
  • LGCB $0.22
  • BCDA $2.50
  • Resistance Level
  • LGCB $0.25
  • BCDA $2.72
  • Average True Range (ATR)
  • LGCB 0.03
  • BCDA 0.22
  • MACD
  • LGCB -0.00
  • BCDA 0.02
  • Stochastic Oscillator
  • LGCB 16.48
  • BCDA 78.48

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: